| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00048 | 1 |